$18.56
0.170.92%
At Close: -
$18.57
0.010.05%
After Hours: 5:03 PM EDT
15 minutes delayed
Comments
Loading...
Teva Pharmaceutical Indus (NYSE:TEVA) Stock, Earnings Estimates, EPS, And Revenue
Teva Pharmaceutical Indus reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Jul 31
EPS
$0.610
Quarterly Revenue
$4.2B
Annual Revenue
(as of Jun 30)
(as of Jun 30)
$16.3B
Analyze the earnings history of Teva Pharmaceutical Indus using advanced sorting and filters.
Data brought to you by Benzinga APIs
Teva Pharmaceutical Indus (TEVA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-07-31 | $0.61 | $0.55 | 10.9 % |
| Mar 2024 | 2024-05-08 | $0.48 | $0.51 | -5.88 % |
| Dec 2023 | 2024-01-31 | $1.00 | $0.77 | 29.9 % |
| Sep 2023 | 2023-11-08 | $0.60 | $0.61 | -1.64 % |
Teva Pharmaceutical Indus (TEVA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-07-31 | $4.16B | $4.06B | 2.56 % |
| Mar 2024 | 2024-05-08 | $3.82B | $3.73B | 2.39 % |
| Dec 2023 | 2024-01-31 | $4.46B | $4.01B | 11.2 % |
| Sep 2023 | 2023-11-08 | $3.85B | $3.72B | 3.49 % |
FAQ
When is Teva Pharmaceutical Indus (NYSE:TEVA) reporting earnings?
Teva Pharmaceutical Indus (TEVA) is scheduled to report earnings on November 6, 2024. The last reported earnings were for reported on July 31, 2024 for Q2.
What were the latest earnings per share (EPS) for Teva Pharmaceutical Indus (NYSE:TEVA)?
The Actual EPS was $0.61, which beat the estimate of $0.55.
What were Teva Pharmaceutical Indus’s (NYSE:TEVA) revenues?
The Actual Revenue was $4.2B, which beat the estimate of $4.1B.
Browse earnings estimates, EPS, and revenue on all stocks.